跳至主要内容
临床试验/EUCTR2022-001697-58-AT
EUCTR2022-001697-58-AT进行中(未招募)1 期

An investigation of clinical outcomes and inflammatory response to heparin free extracorporeal membrane oxygenation support during clinical lung transplantation – a prospective double-blind randomised feasibility study - zero-hep

Medical University of Vienna0 个研究点目标入组 80 人开始时间: 2022年12月2日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Adult recipients over the age of 18 at the time of the procedure, receiving a double lung transplantation (including lungs after ex-vivo lung perfusion) within the Vienna Lung Transplant Program who have given informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Single lung transplantation. Re-transplantation. Previous major thoracic surgery (excluding pleural drainage, VATS biopsy). ECMO bridge to transplantation. COVID-ARDS as transplant indication. Pre-operative anti-coagulation/anti-platelet treatment. Paediatric transplantation. Multi-organ transplantation. Active pregnancy or breastfeeding

研究者

相似试验